Becton Dickinson (BDX) Share-based Compensation (2009 - 2026)
Becton Dickinson's (BDX) quarterly Share-based Compensation came in at $55.0 million in Q2 2026, up 14.58% year-over-year from $48.0 million in Q2 2025, and down 5.17% quarter-over-quarter from $58.0 million in Q1 2026.
Analysis
Becton Dickinson (BDX) Share-based Compensation (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Share-based Compensation for 18 consecutive years, with $55.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 14.58% year-over-year to $55.0 million in Q2 2026; TTM through Jun 2026 was $283.0 million, a 23.04% increase from a year earlier, with the FY2025 full-year figure at $258.0 million, up 4.45% from the prior year.
- Share-based Compensation was $55.0 million for Q2 2026 at Becton Dickinson, down from $58.0 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $91.0 million in Q4 2025 and troughed at $41.0 million in Q1 2025.
- A 5-year average of $62.2 million and a median of $56.0 million in 2023 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 54.9% in 2025, down 31.67% in 2025.
- Over 5 years, Share-based Compensation stood at $89.0 million in 2022, then declined by 6.74% to $83.0 million in 2023, then advanced by 8.43% to $90.0 million in 2024, then climbed by 1.11% to $91.0 million in 2025, then slumped by 39.56% to $55.0 million in 2026.
- The last three Share-based Compensation figures came in at $55.0 million (Q2 2026), $58.0 million (Q1 2026), and $91.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 50.32 Bn | 49.46 Bn | 2.32 Bn | 55.00 Mn |
| 2 | Medline | 48.11 Bn | 52.93 Bn | 2.22 Bn | 274.00 Mn |
| 3 | West Pharmaceutical Services | 23.93 Bn | 23.49 Bn | 329.20 Mn | 10.90 Mn |
| 4 | Baxter International | 13.34 Bn | 11.16 Bn | 1.03 Bn | 33.00 Mn |
| 5 | Stevanato Group S.p.A | 6.21 Bn | 6.11 Bn | 100.91 Mn | -20,922.51 |
| 6 | Acme United | 241.34 Mn | 236.30 Mn | 26.69 Mn | 2.96 Mn |
| 7 | Rockwell Medical | 31.74 Mn | 6.94 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.26 Mn | -18.61 Mn | 190,852.00 | - |
| 9 | United Health Products | 12.24 Mn | 12.21 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 8.09 Mn | 4.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.00 Mn |
| Mar 31, 2026 | 58.00 Mn |
| Dec 31, 2025 | 91.00 Mn |
| Sep 30, 2025 | 79.00 Mn |
| Jun 30, 2025 | 48.00 Mn |
| Mar 31, 2025 | 41.00 Mn |
| Dec 31, 2024 | 90.00 Mn |
| Sep 30, 2024 | 51.00 Mn |
| Jun 30, 2024 | 53.00 Mn |
| Mar 31, 2024 | 60.00 Mn |
| Dec 31, 2023 | 83.00 Mn |
| Sep 30, 2023 | 58.00 Mn |
| Jun 30, 2023 | 56.00 Mn |
| Mar 31, 2023 | 56.00 Mn |
| Dec 31, 2022 | 89.00 Mn |
| Sep 30, 2022 | 49.00 Mn |
| Jun 30, 2022 | 50.00 Mn |
| Mar 31, 2022 | 53.00 Mn |
| Dec 31, 2021 | 81.00 Mn |
| Sep 30, 2021 | 47.00 Mn |